AstraZeneca Partly Resumes Coronavirus Vaccine Trial After Halting It for Safety
The pharmaceutical company AstraZeneca said Saturday that it had resumed its coronavirus vaccine trial in Britain after suspending it six days ago over potential safety issues but that its trials in the United States and other countries were still on hold. The news came the same day that a competitor, Pfizer, said it was expanding…